254 related articles for article (PubMed ID: 23651367)
21. [Clinical evaluation of new quinolones as antituberculosis drugs].
Kawahara S; Tada A; Nagare H
Kekkaku; 1999 Jan; 74(1):71-5. PubMed ID: 10067058
[TBL] [Abstract][Full Text] [Related]
22. Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.
Lipsky BA; Dorr MB; Magner DJ; Talbot GH
Clin Ther; 1999 Jan; 21(1):148-59. PubMed ID: 10090432
[TBL] [Abstract][Full Text] [Related]
23. Grepafloxacin: a review of its safety profile based on clinical trials and postmarketing surveillance.
Lode H; Vogel F; Elies W
Clin Ther; 1999 Jan; 21(1):61-74; discussion 1-2. PubMed ID: 10090425
[TBL] [Abstract][Full Text] [Related]
24. Fluoroquinolone adverse effects and drug interactions.
Fish DN
Pharmacotherapy; 2001 Oct; 21(10 Pt 2):253S-272S. PubMed ID: 11642691
[TBL] [Abstract][Full Text] [Related]
25. Clinical use of the fluoroquinolones.
Owens RC; Ambrose PG
Med Clin North Am; 2000 Nov; 84(6):1447-69. PubMed ID: 11155852
[TBL] [Abstract][Full Text] [Related]
26. Sparfloxacin: a review.
Schentag JJ
Clin Ther; 2000 Apr; 22(4):372-87; discussion 371. PubMed ID: 10823360
[TBL] [Abstract][Full Text] [Related]
27. Adverse reactions to fluoroquinolones. an overview on mechanistic aspects.
De Sarro A; De Sarro G
Curr Med Chem; 2001 Mar; 8(4):371-84. PubMed ID: 11172695
[TBL] [Abstract][Full Text] [Related]
28. Fluoroquinolone toxicity profiles: a review focusing on newer agents.
Lipsky BA; Baker CA
Clin Infect Dis; 1999 Feb; 28(2):352-64. PubMed ID: 10064255
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
30. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
Lipsky BA; Miller B; Schwartz R; Henry DC; Nolan T; McCabe A; Magner DJ; Talbot GH
Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
[TBL] [Abstract][Full Text] [Related]
31. New classification and update on the quinolone antibiotics.
King DE; Malone R; Lilley SH
Am Fam Physician; 2000 May; 61(9):2741-8. PubMed ID: 10821154
[TBL] [Abstract][Full Text] [Related]
32. Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
Sendzik J; Lode H; Stahlmann R
Int J Antimicrob Agents; 2009 Mar; 33(3):194-200. PubMed ID: 18835137
[TBL] [Abstract][Full Text] [Related]
33. Appropriate use of fluoroquinolones in children.
Principi N; Esposito S
Int J Antimicrob Agents; 2015 Apr; 45(4):341-6. PubMed ID: 25726705
[TBL] [Abstract][Full Text] [Related]
34. Glucose homeostasis abnormalities associated with use of gatifloxacin.
Frothingham R
Clin Infect Dis; 2005 Nov; 41(9):1269-76. PubMed ID: 16206101
[TBL] [Abstract][Full Text] [Related]
35. A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects.
Hayem G; Carbon C
Drug Saf; 1995 Dec; 13(6):338-42. PubMed ID: 8652078
[TBL] [Abstract][Full Text] [Related]
36. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
[TBL] [Abstract][Full Text] [Related]
37. Effects of anti-inflammatory drugs on convulsant activity of quinolones: a comparative study of drug interaction between quinolones and anti-inflammatory drugs.
Hori S; Kizu J; Kawamura M
J Infect Chemother; 2003 Dec; 9(4):314-20. PubMed ID: 14691652
[TBL] [Abstract][Full Text] [Related]
38. Use of the quinolones in paediatrics.
Schaad UB
Drugs; 1993; 45 Suppl 3():37-41. PubMed ID: 7689449
[TBL] [Abstract][Full Text] [Related]
39. Side-effects of quinolones: comparisons between quinolones and other antibiotics.
Norrby SR
Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):378-83. PubMed ID: 1864300
[TBL] [Abstract][Full Text] [Related]
40. Safety and tolerability of fluoroquinolones.
Norrby SR; Lietman PS
Drugs; 1993; 45 Suppl 3():59-64. PubMed ID: 7689453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
